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Introduction {#sec1}
============

Electrical and chemical signaling at the synapses between neurons is essential for neural computation. Tools that allow for precise synaptic labeling provide important information regarding connectivity and plasticity and are essential for mapping and understanding neural circuits. Traditional immunohistochemistry methods use antibodies developed against individual endogenous synaptic proteins, which requires fixation of tissue and thus prevents the visualization of live tissues. At the synaptic level, traditional immunohistochemistry non-selectively labels the dense array of synaptic puncta, making it difficult to distinguish or assign particular synaptic puncta to the specific cell from which each synapse originates. Staining for synaptic proteins in particular can be challenging because it is often difficult for large antibodies to penetrate the dense packing of proteins at the postsynaptic density ([@bib39]; [@bib43]; [@bib58]). Several methods have been developed to enhance antibody penetration, but these methods require optimization and often are unreliable ([@bib58]).

Genetically encoded fluorescent proteins enable cell-type specific labeling of live or fixed tissue using cell-type specific promoters or recombinase systems ([@bib47]). Because of the unique bouton-like structure of excitatory synapses, it is possible to use GFP expression to identify excitatory dendritic spines based on shape alone ([@bib11]; [@bib54]). However, this method fails to work for identifying inhibitory synapses that are generally present on the dendritic shaft, or for identifying excitatory synapses on aspiny neurons that do not form distinctive bouton-like structures ([@bib6]; [@bib30]). Expressing exogenous synaptic proteins fused with fluorophores has been used to tag excitatory and inhibitory synapses, offering comparable spatial resolution as antibodies ([@bib2]; [@bib4]; [@bib6]; [@bib37]; [@bib49]; [@bib55]). However, exogenous overexpression of synaptic proteins has the potential to disturb synaptic physiology ([@bib13]). Although the use of transgenic mouse lines with fluorescent proteins fused to endogenous synaptic proteins remains a viable solution ([@bib3]; [@bib16]; [@bib35]; [@bib60]), the timelines for generating specific transgenic lines for each synapse type and fluorophore color of interest has limited such strategies.

Recently, genetically encoded tools have been developed to map functional synapses or label excitatory or inhibitory synapses without modifying endogenous protein levels ([@bib8]; [@bib22]; [@bib28]; [@bib34]). In particular, fibronectin intrabodies generated with mRNA display (FingRs) developed against synaptic proteins PSD95 and gephyrin present a method to fluorescently label excitatory and inhibitory synapses without disrupting endogenous proteins ([@bib22]). PSD95 is a scaffolding protein at excitatory synapses, and gephyrin acts as a scaffolding protein at inhibitory synapses. The genetically encoded FingRs against PSD95 (PSD95.FingR) and against gephyrin (Gephyrin.FingR) bind to PSD95 and gephyrin, respectively, and act as intracellular antibodies in live and fixed neurons. To prevent overexpression of the FingRs, a transcriptional control system has been used to ensure that FingR expression levels matched those of the endogenous protein target ([@bib22]). Because the FingRs bind to the endogenous synaptic proteins, they do not alter the expression levels of endogenous proteins. Furthermore, it has been shown that expression of PSD95.FingR and Gephyrin.FingR does not disrupt synaptic physiology ([@bib22]). These proteins, when introduced through transfection or *in utero* electroporation, have been successfully used in neuron cultures, mouse brain slices, and live transgenic zebrafish ([@bib22]; [@bib27]; [@bib30]; [@bib44]; [@bib57]). Although available in DNA plasmid form, there have been no viral vectors that allow FingRs to be easily used in the brain.

To enable broad application of FingR-based synaptic tagging strategies, we developed a set of PSD95.FingR and Gephyrin.FingR viral vectors. We generated FingR adeno-associated viruses (AAVs), with both strong constitutive and cre-inducible expression, for labeling of excitatory or inhibitory synapses in cortical and subcortical brain regions. We screened a number of red-shifted reporter FingRs with various configurations of red fluorescent proteins (RFP) and FingR fusions and identified that N-terminally fused FingRs retained synaptic targeting specificity. These red FingRs when packaged into AAV viral vectors can be used in conjunction with green FingRs for dual-color synaptic labeling globally, and in a cell-type-specific manner in cre-dependent transgenic mice. Furthermore, we explored the impact of transcriptional control in retroviral vector designs and discovered that the use of a transcriptional control element diminished FingR expression in retroviral vectors. We thus generated FingR retroviral vectors without transcriptional control, which allowed us to label excitatory and inhibitory synapses in adult-born granule cells and track the synaptic development of adult-born neurons throughout the maturation period. Overall, these FingR viral vectors will facilitate neuroscience studies mapping neural circuitry, tracking synaptic development, or studying plasticity, during normal and disease conditions.

Results {#sec2}
=======

Global Labeling of Excitatory and Inhibitory Synapses across Cortical and Subcortical Brain Regions {#sec2.1}
---------------------------------------------------------------------------------------------------

To enable broad application of FingR-based synaptic tagging strategies, we constructed AAV genomic vectors, AAV-EF1α-PSD95.FingR-GFP-CCR5TC and AAV-EF1α-Gephyrin.FingR-GFP-CCR5TC, expressing the PSD95.FingR and Gephyrin.FingR, respectively, under a strong elongation factor-1 alpha (EF1α) promoter and with the CCR5 transcriptional feedback regulator domain (CCR5TC) fused to the C terminus of the GFP ([Figure 1](#fig1){ref-type="fig"}A). The CCR5TC domain consists of a DNA sequence recognizing CCR5 zinc finger protein fused to a KRAB(A) transcriptional repressor domain as described previously ([@bib22]). We then packaged AAV viral particles with AAV9 coat proteins, which exhibit excellent expression levels in the rodent central nervous system ([@bib5]; [@bib17]; [@bib21]; [@bib62]). We injected both viral vectors separately into the cortex, striatum, and hippocampus of the mouse brain and analyzed the expression patterns in each brain region following histochemical processing of fixed brain sections 3 weeks post-injection. We detected strong GFP punctate expression patterns in all brain areas tested, along with labeled cell nuclei ([Figures 1](#fig1){ref-type="fig"}B--1G). The PSD95.FingR puncta density appeared higher than the Gephyrin.FingR density in all brain regions tested, consistent with previous observations of higher excitatory than inhibitory synaptic densities ([@bib36]; [@bib51]; [@bib55]).Figure 1PSD95.FingR and Gephyrin.FingR AAVs Globally Label Excitatory and Inhibitory Synapses with Sub-micron Resolution(A) DNA construct diagrams for (i) PSD95.FingR and (ii) Gephyrin.FingR (GPHN.FingR). Both constructs use the AAV2 transfer backbone and were packaged with the serotype 9 coat proteins. CCR5TC is the transcriptional repressor domain responsible for transcriptional control, which recognizes the CCR5 binding site upstream of the EF1α promoter to regulate the potential for overexpression of the FingR proteins.(B--D) Representative images of PSD95.FingR expression in the motor cortex (B), striatum (C), and hippocampus (D) of mouse brain slices. Images shown at 60× (i), 60× with 4× zoom (ii), and 60× with 20× zoom (iii). Scale bars: 25μm in (i), 10 μm in (ii), and 2 μm in (iii).(E--G) Representative images of Gephyrin.FingR expression in the motor cortex (E), striatum (F), and hippocampus (G) of mouse brain slices. Images shown at 60× (i), 60× with 4× zoom (ii), and 60× with 20× zoom (iii). Scale bars: 25 μm in (i), 10 μm in (ii), and 2 μm in (iii).(H) Brain slices expressing PSD95.FingR (i), stained with a homer antibody (ii), and co-localization (iii). Scale bar, 2 μm.(I) Brain slices expressing Gephyrin.FingR (i), stained with a gephyrin antibody (ii), and co-localization (iii). Scale bar, 2 μm.(J) Quantification of co-localization between synapses labeled with PSD95.FingR, Homer antibody, GPHN.FingR, and gephyrin (GPHN) antibody. PSD95.FingR-labeled synapses co-localized with Homer antibody significantly more than with GPHN antibody, and GPHN.FingR-labeled synapses co-localized with gephyrin antibody significantly more than with Homer antibody (∗∗∗p \< 0.001, two-tailed t test).Data represented as mean ± standard deviation. For additional data, see also [Figures S1](#mmc1){ref-type="supplementary-material"}, [S2](#mmc1){ref-type="supplementary-material"}, and [S8](#mmc1){ref-type="supplementary-material"}.

To verify the identity of the labeled puncta, we used traditional antibody staining and analyzed the co-localization patterns of immunofluorescence and GFP. We found strong co-localization between Gephyrin.FingR-GFP and the gephyrin antibody in mouse brain slices ([Figure 1](#fig1){ref-type="fig"}I), where 69.1% ± 6.0% (mean ± standard deviation, n = 6 slices, from 4 mice) of the Gephyrin.FingR-GFP-positive puncta co-localized with gephyrin immunofluorescence ([Figure 1](#fig1){ref-type="fig"}J). As the PSD95 antibody has difficulty penetrating the postsynaptic density without optimized antigen retrieval methods ([@bib18]), we examined the co-localization of PSD95.FingR-GFP with the excitatory post-synaptic marker Homer and pre-synaptic marker Bassoon in brain slices and found strong co-localization ([Figures 1](#fig1){ref-type="fig"}H and [S1](#mmc1){ref-type="supplementary-material"}) ([@bib9]; [@bib19]; [@bib25]). We found 49.0% ± 10.3% (mean ± standard deviation, n = 6 slices, from 4 mice) of the PSD.FingR-positive puncta co-localized with Homer immunofluorescence ([Figure 1](#fig1){ref-type="fig"}J), which is in line with previous findings ([@bib44]). Furthermore, the PSD95.FingR expressed in neuron culture co-localized with a PSD95 antibody, and co-injection of AAV-EF1α-PSD95.FingR-GFP-CCR5TC and AAV-Syn-PSD95-mCherry showed co-localization in mouse brain slices, further confirming that the PSD95.FingR co-localizes with endogenous PSD95 ([Figure S1](#mmc1){ref-type="supplementary-material"}). As a control, we assessed the co-localization between Gephyrin.FingR-GFP-positive puncta and Homer immunofluorescence, as well as between PSD95.FingR-GFP-positive puncta and gephyrin immunofluorescence and found 0.03% ± 0.02% and 0.11% ± 0.08% (mean ± standard deviation, n = 6 slices, from 2 to 3 mice) co-localization for these control combinations, respectively. Together, these results demonstrate that AAV-EF1α-PSD95.FingR-GFP-CCR5TC and AAV-EF1α-Gephyrin.FingR-GFP-CCR5TC selectively labeled excitatory and inhibitory neurons, respectively, when injected in the mouse brain.

It is useful to note that expression of the AAV-Syn-PSD95.FingR-GFP-CCR5TC under a slightly weaker, but neuron-specific, synapsin promoter still displayed a punctate expression pattern in all three brain regions ([Figure S2](#mmc1){ref-type="supplementary-material"}). We also generated FingR lentiviruses pseudotyped with vesicular stomatitis virus G protein (VSV-G) containing a calmodulin kinase II alpha (CamKIIa) promoter and found that these lentiviruses mediated weak expression in mouse brain slices ([Figure S3](#mmc1){ref-type="supplementary-material"}). The lentivirus designed to express PSD95.FingR-GFP (lenti-CamKIIa-PSD95.FingR-GFP-CCR5TC) showed punctate expression patterns, whereas the lentivirus designed to express Gephyrin.FingR-mRuby2 (lenti-CamKIIa-Gephyrin.FingR-mRuby2-IL2RGTC) only showed expression in the nuclei of cells with no punctate patterns along the dendrites. Overall, the AAV-EF1A-PSD95.FingR-GFP-CCR5TC and AAV-EF1A-Gephyrin.FingR-GFP-CCR5TC viruses enable synaptic labeling in multiple brain regions while maintaining sub-micron spatial resolution.

Generation of a Red Gephyrin.FingR Variant that Enables Dual-Color Synaptic Labeling {#sec2.2}
------------------------------------------------------------------------------------

We next designed a red FingR variant that can be used simultaneously with the green FingRs ([Figure 1](#fig1){ref-type="fig"}) to enable dual-color labeling of both excitatory and inhibitory synapses in the same neurons. Although dual-color synaptic labeling has been shown in neuron cultures and zebrafish, there has been no demonstration of two-color synaptic labeling in mammalian brain tissue using the FingR tags ([@bib22]; [@bib48]). In general, red fluorescent proteins are dimmer, more susceptible to aggregation, and do not function as well in fusion proteins when compared with GFP ([@bib1]). To address this, we selected a bright monomeric red fluorescent protein mScarlet, which exhibits the highest quantum yield and has shown excellent performance as a fusion tag ([@bib1]).

We generated the mScarlet variants of the Gephyrin.FingR using the IL2RG transcriptional control system that is orthogonal to the CCR5 transcriptional control system ([@bib22]; [@bib48]). Because protein fusion could alter FingR binding to its protein target and mScarlet fluorescence levels, we first examined different fusion protein configurations by fusing mScarlet either to the N terminal or to the C terminal of Gephyrin.FingR ([Figure 2](#fig2){ref-type="fig"}A). Interestingly, we found that the N-terminally fused mScarlet-Gephyrin.FingR yielded a much more punctate expression pattern than the C-terminally fused Gephyrin.FingR-mScarlet ([Figures 2](#fig2){ref-type="fig"}B and 2C). This suggests that FingRs are sensitive to protein tagging, and that the location of the fluorophore could impact FingR expression levels and co-localization with endogenous proteins.Figure 2Optimization of a Red Gephyrin.FingR AAV Enables Dual Synaptic Labeling of Excitatory and Inhibitory Synapses(A) DNA construct diagrams for the red Gephyrin AAV variants tested. The IL2RGTC domain acts orthogonally to the CCR5TC domain. The IL2RGTC domain is a transcriptional repressor that recognizes the IL2RG binding site upstream of the EF1A promoter to prevent overexpression of the FingR proteins.(B--E) Representative images of Gephyrin.FingR-mScarlet (B), mScarlet-Gephyrin.FingR (C), mRuby2-Gephyrin.FingR (D), and mCherry-Gephyrin.FingR (E) infected neurons and stained with the gephyrin antibody (i). Zoomed-in images showing synapses stained with the gephyrin antibody (ii), RFP-Gephyrin.FingR expression (iii), and co-localization between RFP and the antibody (iv). Scale bars: 25 μm in (i) and 10 μm in (ii, iii, and iv).(F) DNA construct diagrams for the co-injected viruses PSD95.FingR-GFP (label excitatory synapses in green) and mRuby2-Gephyrin.FingR (label inhibitory synapses in red).(G--J) Representative images of the expression patterns of the co-injected PSD95.FingR-GFP AAV (i) and mRuby2-Gephyrin.FingR AAV (ii) and their merge (iii) in mouse hippocampal brain slices shown at 10× (G), 60× (H), 60× with 4× zoom (I), and 60× with 20× zoom (J). Note the co-localization of cell bodies labeled and non-co-localized punctate synaptic expression, as expected.Scale bars, 200 μm in (G), 25 μm in (H), 10 μm in (I), and 2 μm in (J). For additional data, see also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.

We then further screened other red fluorescent proteins, mRuby2 and mCherry, fused to the N terminal of Gephyrin.FingR based on our findings described earlier ([Figure 2](#fig2){ref-type="fig"}A) ([@bib31]; [@bib42]). In neuron cultures, Gephyrin.FingR-mScarlet, mScarlet-Gephyrin.FingR, and mRuby2-Gephyrin.FingR co-localized with the immunofluorescence of the gephyrin antibody (70.3% ± 4.4%, 69.2% ± 2.5%, and 76.4 ± 3.4% respectively, from 5 fields of view (FOVs) each, [Figures 2](#fig2){ref-type="fig"}B--2D), similar to that achieved by the green gephyrin.FingR-GFP ([Figure 1](#fig1){ref-type="fig"}J). However, mCherry-Gephyrin.FingR largely formed aggregates and showed little expression at the synapses ([Figure 2](#fig2){ref-type="fig"}E). The poor expression of mCherry-Gephyrin.FingR is consistent with previous findings that mCherry aggregates when expressed in neurons ([@bib32]). Together, these results demonstrate that the variants with mScarlet and mRuby2 fused to the N terminal of the Gephyrin.FingR retain the functionality of the FingRs and allow inhibitory synaptic labeling with these red fluorescent proteins.

To demonstrate the use of dual-color synaptic labeling, we co-injected AAV-EF1A-PSD95.FingR-GFP-CCR5TC with the functional red Gephyrin.FingR variant AAV-EF1A-mRuby2-Gephyrin.FingR-IL2RGTC into the mouse brain ([Figure 2](#fig2){ref-type="fig"}F). This way, we could determine not only if the red Gephyrin.FingR properly labels inhibitory synapses but also if it interacts with the PSD95.FingR-GFP. Similar to the neuron culture results, AAV-EF1A-mRuby2-Gephyrin.FingR-IL2RGTC exhibited a punctate expression pattern in mouse brain sections when co-expressed with AAV-EF1A-PSD95.FingR-GFP-CCR5TC, and these two FingRs labeled non-co-localized synaptic puncta (1.3% ± 0.3% co-localization, from 5 FOVs, [Figures 2](#fig2){ref-type="fig"}G--2J). Further validation with the homer and gephyrin antibodies confirmed that PSD95.FingR-GFP labeled excitatory synapses (67.0% ± 3.4% co-localization with homer antibody, and 1.0% ± 0.4% co-localization with gephyrin antibody, from 5 FOVs each), whereas mRuby-gephyrin.FingR labeled inhibitory synapses (76.6% ± 5.2% co-localization with gephyrin antibody and 0% ± 0% co-localization with homer antibody, from 5 FOVs each) ([Figure S5](#mmc1){ref-type="supplementary-material"}). Similarly, AAV-EF1A-mScarlet-Gephyrin.FingR-IL2RGTC and AAV-EF1A-PSD95.FingR-GFP-CCR5TC labeled non-co-localized synaptic puncta in the mouse brain (0% ± 0% co-localization, from 5 FOVs, [Figure S4](#mmc1){ref-type="supplementary-material"}). Thus, AAV-EF1A-PSD95.FingR-GFP-CCR5TC and AAV-EF1A-mRuby2-Gephyrin.FingR-IL2RGTC represent a pair of FingR tags that can be used orthogonally to label both excitatory and inhibitory synapses in the same brain tissue.

Retroviral Vectors Allow Labeling of Excitatory and Inhibitory Synapses in Hippocampal Adult-Born Granule Cells {#sec2.3}
---------------------------------------------------------------------------------------------------------------

Although most neurons are non-dividing, adult neurogenesis occurs in the subventricular and subgranular zones of mammalian brains. Neurons born in the subgranular zone develop into granule cells and functionally integrate into the dentate gyrus of the hippocampus ([@bib53]; [@bib54]; [@bib59]). Several studies have demonstrated important functions of adult neurogenesis in hippocampal-dependent behavioral tasks ([@bib10]; [@bib38]; [@bib61]). Interestingly, adult-born granule cells undergo a critical period about 1 to 2 months after cell birth where they exhibit increased excitability and display heightened plasticity ([@bib20]; [@bib40]).

Adult-born hippocampal granule cells have been shown to first form GABAergic synapses along the dendrites, starting within a week after birth, whereas excitatory synapses and dendritic spines do not form until 2 weeks after birth in mice ([@bib52]). Peak spine formation occurs during the third week after birth, coinciding with the observed critical development window important for their function ([@bib52]). Although several studies have outlined the detailed timeline for synaptic development in adult-born granule cells using electrophysiology and cell morphology, it remains difficult to study the synapses on newborn cells in isolation. Although antibodies exist for labeling excitatory and inhibitory synapses, it is impossible to distinguish synapses formed onto adult-born granule cells from those onto mature dentate granule cells, even if the adult-born cells are labeled with fluorescent proteins. Genetically encoded FingR synaptic tags can overcome these issues by only labeling synapses within adult-born neurons.

To express the PSD95.FingR and Gephyrin.FingR in adult-born neurons, we used a murine stem cell virus (MSCV) retroviral expression system with a synapsin promoter that has been shown to mediate strong and specific gene expression in adult-born dentate granule cells born within a day of viral injection ([@bib61]). The negative feedback transcriptional control of the FingR proteins ensures that transgene expression matches the levels of endogenous proteins, whereas our lentivirus mediated low levels of FingR expression as demonstrated in [Figure S3](#mmc1){ref-type="supplementary-material"}. As lentivirus pseudotyped with VSV-G is known to have similar or slightly higher transduction efficiency than MSCV retrovirus, we constructed retroviral vectors containing synapsin-driven FingR-GFP expression, with and without transcriptional control. Upon initial testing in HEK cells, we could not detect any GFP fluorescence in the transcriptionally regulated retrovirus FingR variants ([Figure S6](#mmc1){ref-type="supplementary-material"}). Thus, we injected retrovirus MSCV-Syn-PSD95.FingR-GFP and MSCV-Syn-Gephyrin.FingR-GFP, without transcriptional control, and an MSCV-Syn-GFP control virus into the dentate gyrus of adult mice, and analyzed synaptic puncta 4 weeks after the viral injections ([Figures 3](#fig3){ref-type="fig"}A and 3B). We found that MSCV-Syn-FingR-GFP-labeled neurons exhibited a distinct and punctate GFP expression pattern ([Figure 3](#fig3){ref-type="fig"}B) and also showed weak fluorescence in the dendrites, which can be used for visualizing the dendritic tree. Synaptic puncta were brighter and could be distinguished from the dendrites. In contrast, in control mice injected with MSCV-Syn-GFP, labeled adult-born neurons showed more uniform expression along the dendrites, without punctate structures, further confirming that the synaptic punctate expression pattern is due to PSD95.FingR- and Gephyrin.FingR-directed binding to synaptic proteins. As expected, the PSD95.FingR expression was concentrated in the dendritic spines where over 90% of excitatory synapses are formed ([@bib26]), whereas the Gephyrin.FingR puncta were generally confined to the dendritic shaft as described previously for inhibitory synapses ([@bib6]; [@bib30]).Figure 3Retroviral FingRs Enable Tracking of Synaptic Development of Adult-Born Dentate Granule Cells throughout Maturation(A) DNA construct diagrams for the retroviruses used in this study. (i) GFP control, (ii) PSD95.FingR-GFP (no transcriptional control), and (iii) Gephyrin.FingR-GFP (no transcriptional control).(B) Representative images of (i) GFP, (ii) PSD95.FingR-GFP, and (iii) Gephyrin.FingR-GFP expression in 4-week-old adult-born cells. Scale bar, 2 μm.(C) Timeline of retroviral injections and subsequent perfusion of mice for tracking synaptic development in adult-born neurons.(D--F) Representative images of the expression patterns of PSD95.FingR-GFP in adult-born cells at 2 weeks (D), 4 weeks (E), and 12 weeks (F) following birth. Cells were imaged at 60× (i), 60× with a 4× zoom (ii and iii), and 60× with a 20× zoom (iv). Scale bars: 25 μm in (i), 10 μm in (ii and iii), and 2μm in (iv).(G--I) Representative images of the expression patterns of Gephyrin.FingR-GFP in adult-born neurons at 2 weeks (G), 4 weeks (H), and 12 weeks (I) following birth. Cells were imaged at 60× (i), 60× with a 4× zoom (ii and iii), and 60× with a 20× zoom (iv). Scale bars: 25 μm in (i), 10 μm in (ii and iii), and 2 μm in (iv).(J and K) Quantification of synaptic density (synapses per 100 μm) of excitatory (J) and inhibitory (K) synapses at 2, 4, and 12 weeks following cell birth (one-way ANOVA with post-hoc Bonferroni correction, ∗p \< 0.05). Data represented as mean ± standard error.

By examining MSCV-Syn-PSD95.FingR-GFP- and MSCV-Syn-Gephyrin.FingR-GFP-labeled neurons at different time points after viral injection, we were able to track excitatory and inhibitory synapse formation throughout the maturation period by euthanizing mice at 2, 4, and 12 weeks following cell birth ([Figure 3](#fig3){ref-type="fig"}C) ([@bib52]; [@bib54]). In PSD95.FingR-injected mice, we observed that although 2-week-old adult-born cells have developed dendrites protruding into the molecular layer, they have formed few excitatory synaptic puncta (12 ± 9 synapses per 100 μm, mean ± standard error, 4,709 μm dendrite length examined in 31 FOVs from 3 mice, [Figures 3](#fig3){ref-type="fig"}D and 3J). By 4 weeks of age, a significantly denser labeling was evident and mainly restricted to the dendritic spines, with a synaptic density of 97 ± 11 synapses per 100 μm (7,379 μm dendrite length, examined in 39 FOVs from 4 mice, [Figures 3](#fig3){ref-type="fig"}E and 3J, one-way ANOVA with post-hoc Bonferroni correction comparing 4 weeks versus 2 weeks, p \< 0.005), consistent with previous studies ([@bib50]; [@bib53]; [@bib54]). By 12 weeks of age, synapse density was further increased, but not significantly different from that at 4 weeks of age (132 ± 11 synapses per 100 μm, 7,657 μm dendrite length, examined in 35 FOVs from 3 mice at 12 weeks, [Figures 3](#fig3){ref-type="fig"}F and 3J, one-way ANOVA with post-hoc Bonferroni correction compared with that of 4 weeks, p = 0.27, compared with 2 weeks, p \< 0.001).

Although dendritic spines outlined by soluble GFP expression have previously been used as a surrogate for excitatory synapses, it has not been possible to visualize inhibitory synapses based on morphology ([@bib6]; [@bib30]). In mice injected with MSCV-Syn-Gephyrin.FingR-GFP, we found that 2-week-old adult-born neurons formed sparse GABAergic synaptic puncta along their dendrites (5 ± 3 synapses per 100 μm, 3,440 μm dendrite length examined in 27 FOVs from 3 mice, [Figures 3](#fig3){ref-type="fig"}G and 3K). By 4 weeks of age, we observed a moderate increase in the density of inhibitory synapses (13 ± 2 synapses per 100 μm, 14,341 μm dendrite length, examined in 50 FOVs from 4 mice, [Figures 3](#fig3){ref-type="fig"}H and 3K, one-way ANOVA with post-hoc Bonferroni correction comparing 4 weeks versus 2 weeks, p = 0.066), and at 12 weeks of age, the inhibitory synaptic density further increased to 16 ± 1 inhibitory synapses per 100 μm (4,635 μm dendrite length, examined in 27 FOVs from 3 mice, [Figures 3](#fig3){ref-type="fig"}I and 3K, one-way ANOVA with post-hoc Bonferroni correction compared to that of 4 weeks, p = 0.69, compared to 2 weeks, p \< 0.05). Thus, for the development of both excitatory and inhibitory synapses, the largest increase in synaptic density occurred between weeks 2 and 4 with a more gradual increase between 4 and 12 weeks.

Cre-Inducible AAV FingR Viral Vectors Allow Synaptic Labeling of Striatal Aspiny Cholinergic Interneurons {#sec2.4}
---------------------------------------------------------------------------------------------------------

Although several studies have explored the density of excitatory synaptic spines on projection neurons in the cortex, hippocampus, and striatum, little is known about the synaptic density of aspiny neurons, such as striatal cholinergic interneurons, due to the lack of spines. Striatal cholinergic interneurons only make up 1%--2% of striatal cells, but they have been implicated in movement behavior and learning ([@bib21]; [@bib33]). To label the synapses of aspiny cholinergic interneurons, we generated cre-inducible AAV FingR vectors containing a double inverted operator (DIO). We co-injected AAV-DIO-mRuby2 and AAV-DIO-Gephyrin.FingR-GFP-CCR5TC to label inhibitory synapses, or AAV-DIO-mRuby2 and AAV-DIO-PSD95.FingR-GFP-CCR5TC to label excitatory synapses, into the striatum of ChAT-cre mice ([Figures 4](#fig4){ref-type="fig"}A and 4C). We found that AAV-DIO-mRuby2 labeled cholinergic interneurons\' cell bodies and their dendrites uniformly red and AAV-DIO-Gephyrin.FingR-GFP-CCR5TC successfully labeled inhibitory synapses that appear in a punctate manner in green ([Figure 4](#fig4){ref-type="fig"}B). Similarly, AAV-DIO-PSD95.FingR-GFP-CCR5TC labeled excitatory synapses as green puncta ([Figure 4](#fig4){ref-type="fig"}D). We confirmed that mRuby2/FingR expression was limited to cholinergic interneurons using antibody staining as expected ([Figure S7](#mmc1){ref-type="supplementary-material"}). The cre-lox system is a powerful tool for genetic targeting of distinct cell types expressing cre recombinase, and hundreds of transgenic cre mouse lines have been developed ([@bib41]). The AAV-DIO-FingRs generated here can be used with the vast number of cre-transgenic mouse lines to understand the synaptome of various cell types.Figure 4Cre-Inducible FingR Variants Label Synapses in Aspiny Striatal Cholinergic Interneurons(A) DNA construct diagrams for labeling of cre-expressing neurons and their inhibitory synapses.(B) 60× (i--iii) and 60× with 20× zoom (iv--vi) representative images of cholinergic interneurons with inhibitory synapses labeled in green (i and iv), cell bodies and dendrites labeled in red (ii and v), and a merge of both channels (iii and vi). Scale bars: 25 μm in (i--iii) and 2 μm in (iv--vi).(C) DNA construct diagrams for labeling of neurons and excitatory synapses.(D) 60× (i--iii) and 60× with 20× zoom (iv--vi) representative images of cholinergic interneurons with excitatory synapses labeled in green (i and iv), cell bodies and dendrites labeled in red (ii and v), and a merge of both channels (iii and vi). Scale bars: 25 μm in (i--iii) and 2 μm (iv--vi).(E) Experimental timeline of virus injection, 6-OHDA injection, and perfusion of animals.(F) Representative 60× with 4× zoom (top, i--iv) and 20× zoom (bottom, v--viii) images of a cholinergic interneuron with inhibitory synapses labeled with Gephyrin.FingR-GFP (i, v) and the whole cell labeled with mRuby2 (ii, vi) along with tyrosine hydroxylase (TH) staining for dopaminergic terminals (iii, vii); the overlay of the three images (iv, viii) in the non-lesioned hemisphere of striatum. Scale bar: 10 μm for images on the top and 2 μm for images on the bottom.(G) Representative 60× with 4× zoom (top, i--iv) and 20× zoom (bottom, v--viii) images of a cholinergic interneuron with inhibitory synapses labeled with Gephyrin.FingR-GFP (i, v) and the whole cell labeled with mRuby2 (ii, vi) along with TH staining for dopaminergic terminals (iii, vii), the overlay of the three images (iv, viii) in the lesioned hemisphere of striatum. Scale bar, 10 μm for images on the top (i--iv) and 2μm for images on the bottom (v--viii).(H) Quantification of inhibitory synaptic density in cholinergic interneurons with and without 6-OHDA lesioning. p \> 0.05, no significant difference, Wilcoxon rank-sum test.Data represented as mean ± standard error. For additional data, see also [Figure S7](#mmc1){ref-type="supplementary-material"}.

In dopamine-depleted Parkinson disease (PD) mouse models, it has been noted that the striatum undergoes synaptic reorganization in response to loss of dopaminergic input. Dopamine depletion leads to spine loss in inhibitory medium spiny neurons (MSNs) ([@bib56]), which could decrease MSN output to cholinergic neurons. We thus examined the impact of dopamine depletion on inhibitory synapses in cholinergic neurons. We co-injected cre-inducible AAV-DIO-mRuby2 and AAV-DIO-Gephyrin.FingR-GFP-CCR5TC into both hemispheres of the striatum in ChAT-cre mice. After 1 week, we unilaterally injected the neurotoxin 6-OHDA into the striatum to selectively deplete dopaminergic inputs to that hemisphere of striatum. Three weeks following the 6-OHDA injection, we validated dopamine depletion with tyrosine hydroxylase antibody staining ([Figures 4](#fig4){ref-type="fig"}E, 4F, and 4G, see [Figure S7](#mmc1){ref-type="supplementary-material"} for whole brain slice), and quantified the synaptic density in the lesioned versus non-lesioned hemispheres. Interestingly, we did not observe a noticeable difference in inhibitory synaptic density between the two hemispheres, suggesting that dopamine depletion does not result in inhibitory synaptic remodeling in striatal cholinergic interneurons 3 weeks after dopamine depletion ([Figures 4](#fig4){ref-type="fig"}F--4H). Together, these experiments demonstrate the breadth of studies enabled by these cre-inducible AAV FingR viral vectors in analyzing synaptic reorganization that accompanies disease models.

Discussion {#sec3}
==========

We engineered a viral toolbox of genetically encoded fluorescent synaptic tags that allow broad applications of FingR-based synaptic tagging of excitatory and inhibitory synapses in the mouse brain in a global or cell-specific manner. We screened a number of red-shifted reporter FingRs with RFPs fused to the N versus C terminus of the FingR and identified that N-terminally fused FingRs retained synaptic targeting specificity better than the C-terminally fused FingRs. The red FingR AAV viral vectors, when used in conjunction with the GFP-tagged green FingRs, allowed for dual-color synaptic labeling globally and can be applied in a cell-type-specific manner in cre-dependent transgenic mice. Furthermore, we explored the impact of transcriptional control in retroviral vector designs and found that the inclusion of transcriptional control elements diminished FingR expression in retroviral vectors due to the generally lower titer of the retrovirus compared with AAV viral vectors. By removing the transcriptional control, we generated FingR retroviral vectors that allowed us to estimate the density of excitatory and inhibitory synapses in adult-born granule cells during synaptic maturation. In addition, the cre-dependent AAV FingR variants enabled us to quantify the density of inhibitory synapses in cholinergic interneurons in healthy and diseased brains. Overall, the toolbox of FingR viral vectors generated here provides a powerful method for mapping the synaptome and understanding synaptic changes during development or plasticity related to learning or disease.

The development of the red Gephyrin.FingR demonstrates the possibility of engineering high-performance FingRs with different fluorophores. Our efforts highlight that not all fluorophores perform well when fused to FingRs, and certain variants, such as mCherry, interfere with FingRs binding to their protein target. In addition, we found that fluorophores fused to the N terminus of FingRs retained better synaptic targeting specificity than those fused to the C terminus. These results highlight the nuanced nature of molecular engineering, where a few mutations within the linker region between two protein domains could alter the functionality of the linked domains. For example, mutations at the linker region between GFP and the CaM-binding domain drastically altered the performance of the engineered genetically encoded calcium sensor GCaMP ([@bib7]).

Dual labeling of excitatory and inhibitory synapses is useful in understanding the excitation/inhibition balance in different brain regions and how this balance is altered during neuronal maturation or in disease states. The AAV FingRs can be stereotaxically delivered via intracranial injection to any brain region and can be confined to small structures by adjusting the volume of virus injected. Less-invasive synaptic labeling can also be performed by tail vein or facial vein injections of AAVs ([@bib5]; [@bib17]; [@bib62]). In addition, AAV FingR labeling can help overcome the technical difficulty associated with the antibodies that cannot efficiently penetrate the densely packed post-synaptic density ([@bib39]; [@bib43]; [@bib58]).

We found that similar to Gross et al. and Son et al., AAV viral vectors with transcriptional regulation of FingR protein expression yielded punctate expression in the dendrites and reduced background signal in the dendrites ([@bib22]; [@bib48]). As expected, we also saw fluorescence in the cell nucleus due to the targeting of the FingR protein back to the nucleus for autoregulation. In addition, the PSD95.FingR and Gephyrin.FingR co-expressed in a punctate manner during dual synaptic labeling experiments, demonstrating that the two orthogonal zinc finger transcriptional control systems exhibited no cross talk when used in conjunction in the mouse brain. However, we found that the FingR retroviruses containing transcriptional control resulted in nearly no expression when tested, due to the generally lower titer of the retrovirus. By removing transcriptional control, the FingR retroviruses successfully tagged excitatory and inhibitory synapses. The low-level background fluorescent signal in the dendrites of retrovirus-labeled neurons in fact made it possible to visualize the individual cell from which each synapse was affiliated.

Although several studies have outlined the timeline of synaptic formation in adult neurogenesis, we here provide visualization of the location of inhibitory synapses and quantification of the density of inhibitory synapses during the maturation of these cells. Previously, inhibitory synapses were identified using electrophysiology and GABA agonists or antagonists ([@bib14]). Our data provide direct experimental evidence that the earliest GABAergic synapses form within 14 days after cell birth, and the number of synapses increases during maturation. Although GABA afferents are present as early as 1 week after birth, some cells do not develop functional synapses until after 2 weeks of age ([@bib14]). Electrophysiology studies suggest that perisomatic inhibitory synapses form in cells by 4 weeks after birth ([@bib14]; [@bib52]). Unfortunately, we were not able to accurately confirm this due to the higher concentration of Gephyrin.FingR protein in the soma. In addition, it is interesting that we found that the largest increase in inhibitory synaptic density comes between 2 and 4 weeks after cell birth, which coincides with the large increase in the number of excitatory synapses and the widely observed critical period. This could likely be a homeostatic mechanism for the cell to maintain its excitation/inhibition balance.

Many studies have explored the density of excitatory and inhibitory synapses in pyramidal cells in the cortex ([@bib6]; [@bib30]; [@bib55]) and tracked the absolute number and ratio of synapses in hippocampal pyramidal cells and interneurons ([@bib24]; [@bib36]). In the striatum, most studies have focused on studying the number of spines on the MSNs ([@bib11]). Striatal cholinergic interneurons receive excitatory inputs from the cortex and thalamus, inhibitory inputs generally from the local MSNs and parvalbumin neurons, and dopaminergic inputs from the substantia nigra pars compacta ([@bib12]; [@bib33]). Recent studies have also identified inputs to cholinergic interneurons using monosynaptic tracing ([@bib29]). Only two studies have specifically identified synapse density in striatal cholinergic interneurons, and this was done using electron microscopy ([@bib46], [@bib45]). The ∼0.36 inhibitory synapses per micron we found is consistent with the results reported in these two studies, but we were able to do this using confocal microscopy over broad regions of tissue, quantifying thousands of synapses with the FingRs, whereas the electron microscopy studies only examined tens of synapses ([@bib46], [@bib45]).

We found no significant changes in the density of inhibitory synapses following 6-OHDA lesioning at 3 weeks, suggesting that dopamine depletion does not immediately induce plasticity changes at inhibitory synapses in cholinergic interneurons. However, because we only quantified synapses at one time point after dopamine depletion, it is unclear whether there is a simultaneous addition and subtraction of synapses that may be occurring or if depletion could result in a reduction in synapses over a longer timescale not analyzed here. Future studies using FingRs in different striatal cell types could provide a more comprehensive analysis of structural remodeling upon dopamine depletion.

One key advantage of the set of FingR viral vectors developed here are their flexibility for future studies. These viruses can be used in transgenic mice or combined with other viral vectors. In particular, the red FingR variants can be used to identify synapses while working with commonly used green fluorescent sensors such as GCaMP ([@bib7]). The mScarlet and mRuby2 FingR tags developed here can be used in conjunction with near-infrared fluorescent proteins without spectral overlap ([@bib15]), allowing potential applications beyond dual color toward more color combinations. In addition, the development of a similar genetically encoded presynaptic tag will enable the study of synapses in greater detail. These probes are also compatible with super-resolution imaging methods such as PALM and STORM to further improve spatial resolution ([@bib44]). Future studies with longitudinal *in vivo* imaging of the FingRs will yield insight into the formation and pruning of individual synapses over days and weeks. Finally, the FingRs can act as a targeting sequence for other genetically encoded tools to localize their expression to the synapses ([@bib23]; [@bib44]). We believe this toolbox of FingR viruses will prove useful for a variety of applications and enable numerous future neuroscience studies.

Limitations of the Study {#sec3.1}
------------------------

In this study, the FingR viral vectors were tested in three major brain regions: the cortex, hippocampus, and striatum. We validated synaptic targeting using antibody co-localization in the hippocampus, but did not repeat this in all brain regions studied. However, the punctate expression patterns and higher density of PSD95.FingR-labeled synapses than Gephyrin.FingR-labeled synapse suggest that the FingR vectors correctly identify excitatory and inhibitory synapses. Furthermore, the synaptic densities we report for excitatory synapses in adult-born granule cells and for inhibitory synapses in striatal cholinergic interneurons are in line with previous studies ([@bib46], [@bib45]; [@bib50]; [@bib53]; [@bib54]).

Although we demonstrated that dual-color labeling of excitatory and inhibitory synapses in the same neurons is possible as shown in [Figure 2](#fig2){ref-type="fig"}, this current study did not include red variants of the retroviral or AAV cre-inducible FingR vectors. In addition, whereas we examined inhibitory synapse formation on dendrites in adult-born granule cells ([Figure 3](#fig3){ref-type="fig"}), we were not able to look at synapses on the soma of adult-born granule cells due to the buildup of fluorescent protein in the cell body without transcriptional control. As noted in the earlier discussion, the addition of a transcriptional control unit greatly diminished the overall fluorescence of the FingR proteins in retroviral vectors, making it difficult to identify individual synapses in adult-born granule cells.

We quantified synaptic densities in adult-born granule cells and dopamine-depleted aspiny striatal cholinergic interneurons over time in fixed brain sections, and thus we were able to capture the synaptic density only at a given time point in each animal. However, this is a limitation of the quantification techniques used in this study, rather than the FingR viral vectors. Deploying high-resolution *in vivo* imaging techniques, future studies should be able to track dynamic changes of synapses over time in the same animal.

Resource Availability {#sec3.2}
---------------------

### Lead Contact {#sec3.2.1}

Additional resources related to this study are available upon reasonable request from the Lead Contact (Xue Han, <xuehan@bu.edu>).

### Materials Availability {#sec3.2.2}

Plasmids used in this study and their sequences are available at [Addgene.org](http://Addgene.org){#intref0015} (AAV-EF1A-PSD95.FingR-eGFP-CCR5TC, 125691; AAV-EF1A-Gephyrin.FingR-eGFP-CCR5TC, 125692; AAV-Syn-PSD95.FingR-eGFP-CCR5TC, 125693; AAV-Syn-PSD95-mCherry, 125694; AAV-EF1A-mScarlet-Gephyrin.FingR-IL2RGTC, 125695; AAV- EF1A-mRuby2-Gephyrin.FingR-IL2RGTC, 125696; MSCV-Syn-PSD95.FingR-eGFP, 126212; MSCV-Syn-Gephyrin.FingR-eGFP, 126213; AAV-EF1A-DIO-mRuby2, 126215; AAV-EF1A-DIO-PSD95.FingR-eGFP-CCR5TC, 126216; AAV-EF1A-DIO-Gephyrin.FingR-eGFP-CCR5TC, 126217; Lenti-CamKII-PSD95.FingR-eGFP-CCR5TC, 126218).

### Data and Code Availability {#sec3.2.3}

The data used in this study are available upon reasonable request from the Lead Contact (Xue Han, <xuehan@bu.edu>). Computer code used to generate results for this study is available at <https://github.com/HanLabBU/>Synaptic-puncta-quantification. Sequences of the generated DNA plasmids are available at GenBank via the following accession numbers: GenBank: MT586119 for AAV-EF1A-mScarlet-Gephyrin.FingR-IL2RGTC; GenBank: MT612428 for AAV-EF1A-mRuby2-Gephyrin.FingR-IL2RGTC; MT612429 for AAV-EF1A-PSD95.FingR-GFP-CCR5TC; GenBank: MT612430 for AAV-EF1A-DIO-PSD95.FingR-GFP-CCR5TC; GenBank: MT612431 for AAV-EF1A-DIO-Gephyrin.FingR-GFP-CCR5TC; GenBank: MT612432 for AAV-EF1A-Gephyrin.FingR-GFP-CCR5TC; GenBank: MT612433 for MSCV-syn-PSD95.FingR-GFP; and GenBank: MT612434 for MSCV-syn-Gephyrin.FingR-GFP.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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